These findings are in line with previous reports revealing IgG3 deficiency to be the most frequent in ME/CFS patients, with 64% of ME/CFS patients having decreased IgG3 titers [26]. This evidence concerns the gene IGHG3 and hyperinsulinemic hypoglycemia, familial, 4.